Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2017-05-05 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
2017年限制性股票激励计划（草案）
Board/Management Information Classification · 95% confidence The document is a detailed draft of a restricted stock incentive plan for SanNuo Bio-sensing Co., Ltd. It includes comprehensive information about the stock incentive plan, such as the purpose, scope, management, stock source, quantity, pricing, vesting and unlocking conditions, performance targets, and legal compliance references. The document is lengthy (15,000 characters) and contains substantive content about the company's management and governance related to stock incentives. It is not a brief announcement or a simple notification but a full plan draft. This type of document fits best under the category of Board/Management Information (MANG), as it relates to management decisions and governance about stock incentives for executives and key employees. It is not an Annual Report, Audit Report, or Earnings Release, nor is it a regulatory filing or proxy solicitation. Therefore, the classification is MANG with high confidence.
2017-05-05 Chinese
监事会关于公司2017年限制性股票激励计划激励对象人员名单的核查意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from the Supervisory Board of SanNuo Bio-sensing Co., Ltd. regarding the verification of the list of incentive recipients under the company's 2017 restricted stock incentive plan. It references relevant laws and regulations concerning stock incentive plans and confirms the eligibility and compliance of the incentive recipients. The document is not a financial report, earnings release, or management discussion but rather a regulatory compliance and verification statement related to a stock incentive plan. It does not announce voting results, changes in management, or capital structure changes. Given the nature of the document as a formal verification opinion related to a stock incentive plan, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories. The document length is short (1144 characters), and it is not an announcement of a report publication but a substantive regulatory statement.
2017-05-05 Chinese
股权激励计划自查表
Regulatory Filings Classification · 95% confidence The document is a detailed compliance self-checklist related to a company's equity incentive plan, including regulatory compliance, internal controls, performance metrics, and legal opinions. It does not contain financial statements or earnings data, nor is it an announcement or presentation. It is a regulatory compliance document related to governance and internal controls but does not fit the categories of Annual Report, Interim Report, or Audit Report. It is not a report publication announcement since it contains substantive content rather than a brief notice. The document is best classified under Regulatory Filings (RNS) as it is a compliance checklist related to regulatory requirements for equity incentive plans.
2017-05-05 Chinese
第三届监事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the sixth meeting of the third Supervisory Board of the company. It details the approval of a restricted stock incentive plan draft, its implementation assessment methods, and verification of the incentive recipients list. The document includes voting results and references to compliance with relevant laws and regulations. It is an official announcement of board-level decisions related to management incentives, not a full management report or financial statement. It does not contain financial data or detailed financial analysis, nor is it a report publication announcement. The content fits best under Board/Management Information (MANG) as it relates to governance decisions and management incentive plans.
2017-05-05 Chinese
关于第一期员工持股计划实施的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of the company's first employee stock ownership plan (员工持股计划). It details the purchase of company shares through market transactions and provides specific transaction data. The document is relatively short (1672 characters) and focuses on the implementation progress of a capital-related employee stock plan. It is not a full financial report, earnings release, or management discussion. It is also not a regulatory certification or a voting result announcement. The content fits best under Capital/Financing Update (CAP) as it relates to financing activities involving employee stock ownership plans and share purchases by a trust. Therefore, the appropriate classification is CAP with high confidence.
2017-04-25 Chinese
关于实际控制人减持股份的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the reduction of shares held by an actual controller of the company, detailing the number of shares sold, the method of sale, and the impact on shareholding percentages. It includes compliance statements with regulatory requirements and confirms that the controlling status remains unchanged. This type of document is a notification of a director or significant shareholder's personal share transactions, specifically a reduction in holdings. It does not contain financial statements, earnings data, or management discussion, nor is it a report or presentation. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused solely on shareholding changes by a director, confirming the classification with high confidence.
2017-04-25 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.